secwatch.observer — SEC 8-K summary
======================================

Issuer:     Milestone Pharmaceuticals Inc. (MIST)
CIK:        0001408443
Form:       8-K
Filed at:   2025-03-18T23:59:59+00:00
Accession:  0001104659-25-025055
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Milestone Pharmaceuticals amends ATM sales agreement with Jefferies to up to $77.8M
--------------------------------------------------------------------------------

- Amended Open Market Sale Agreement replaces prior $50M facility; total capacity increased to $77.8M including ~$2.8M already sold.
- Common shares sold at-the-market via Jefferies; company pays 3.0% commission on gross proceeds.
- Prospectus supplement to be filed under existing S-3 shelf registration (File No. 333-283162).
- Company not obligated to sell any shares; agreement may be terminated early by either party.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1408443/000110465925025055/0001104659-25-025055-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1408443/000110465925025055/tm259429d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-025055

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer